WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Mets Brain Tumors efficacy endpoints v test, Tumor Subtype by Molecular Characteristics ???? - luminal - HER2-positive - basal - TNBC, perpendicular diameter measured in plane, Sum of the product of all lesions has outcomes -Complete Response (CR) -Partial Response (PR) -Stable disease (SD) -Progression, Enhancing classified as Non-measurable lesions, Qualitative Assessment has attribute - better - same - worse, New lesion identified by Organ specific lesion ID, Regional includes Convection enhanced delivery, Sum of the product of all lesions includes Total area of each leasion, Enhancing classified as Existing lesion, PRIMARY BRAIN TUMORS (HGG) EFFICACY ENDPOINTS include Overall Survival (OS), RECIST ???? Enhancing, Regional includes Surgical Resection, Repeated concepts/instances throughout the CMAP are denoted by dotted outline, Therapeutic Efficacy Endpoint is intersection of Therapeutic Intervention, Disease characteristics include Tumor Origin, plane has attribute - axial - other, Prior Therapy include Regional, CT ???? - with contrast without contrast, Surgical Resection instantiated by - yes - no, HRQoL instantiated by - FACT-BR - MDASI - EORTCQLQ - Other